IL-12 and IL-18 levels in serum and gingival tissue in aggressive and chronic periodontitis

Oral Diseases

Volumn 17, Issue 5, 2011, Pages 522-529

  Sanchez Hernandez P E ^a   Zamora Perez, A L ^a   Fuentes Lerma, M ^a   Robles Gomez C ^a   Mariaud Schmidt, R P ^a   Guerrero Velazquez C ^a  

^a UNIVERSITY OF GUADALAJARA   (Mexico)

Author keywords

Interleukin 12; Interleukin 18; Periodontitis

Indexed keywords

INTERLEUKIN 12; INTERLEUKIN 18;

ADULT; AGGRESSIVE PERIODONTITIS; ARTICLE; BIOPSY TECHNIQUE; CHRONIC PERIODONTITIS; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GINGIVA; HUMAN; HUMAN TISSUE; MALE; PERIODONTAL DISEASE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL;

ADOLESCENT; ADULT; AGE FACTORS; AGGRESSIVE PERIODONTITIS; BIOPSY; CHRONIC PERIODONTITIS; DENTAL PLAQUE INDEX; FEMALE; GINGIVA; GINGIVAL HEMORRHAGE; HUMANS; INTERLEUKIN-12; INTERLEUKIN-18; MALE; MIDDLE AGED; PERIODONTAL ATTACHMENT LOSS; PERIODONTAL INDEX; PERIODONTAL POCKET; PERIODONTIUM; YOUNG ADULT;

EID: 79957970148     PISSN: 1354523X     EISSN: 16010825     Source Type: Journal    
DOI: 10.1111/j.1601-0825.2011.01798.x     Document Type: Article

References (65)

1. Altare F, Durandy A, Lammas D et al (1998). Impairment of mycobacterial immunity in human interleukin-12 receptor deficiency. Science 280: 1432-1435.
2. Armitage GC (1999). Development of a classification system for periodontal diseases and conditions. Ann Periodontol 4: 1-6.
3. Armitage GC, Robertson PB (2009). The biology, prevention, diagnosis and treatment of periodontal diseases: scientific advances in the United States. J Am Dent Assoc 140(Suppl 1): 36S-43S.
4. Bradford MM (1976). A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72: 248-254.
5. Buchmann R, Hasilik A, Van Dyke TE, Lange DE (2002). Amplified crevicular leukocyte activity in aggressive periodontal disease. J Dent Res 81: 716-721.
6. Cairo F, Nieri M, Gori AM et al (2010). Markers of systemic inflammation in periodontal patients: chronic versus aggressive periodontitis. An explorative cross-sectional study. Eur J Oral Implantol 3: 147-153.
7. Cardoso CR, Garlet GP, Crippa GE et al (2009). Evidence of the presence of T helper type 17 cells in chronic lesions of human periodontal disease. Oral Microbiol Immunol 24: 1-6.
8. Cochran DL (2008). Inflammation and bone loss in periodontal disease. J Periodontol 79: 1569-1576.
9. Dinarello CA, Fantuzzi G (2003). Interleukin-18 and host defense against infection. J Infect Dis 187(Suppl 2): S370-S384.
10. Duarte PM, da Rocha M, Sampaio E et al (2010). Serum levels of cytokines in subjects with generalized chronic and aggressive periodontitis before and after non-surgical periodontal therapy: a pilot study. J Periodontol 81: 1056-1063.
11. Dutzan N, Vernal R, Hernandez M et al (2009). Levels of interferon-gamma and transcription factor T-bet in progressive periodontal lesions in patients with chronic periodontitis. J Periodontol 80: 290-296.
12. Figueredo CM, Rescala B, Teles RP et al (2008). Increased interleukin-18 in gingival crevicular fluid from periodontitis patients. Oral Microbiol Immunol 23: 173-176.
13. Foster N, Andreadou K, Jamieson L, Preshaw PM, Taylor JJ (2007). VIP inhibits P. gingivalis LPS-induced IL-18 and IL-18BPa in monocytes. J Dent Res 86: 883-887.
14. Garlet GP, Martins W Jr, Ferreira BR, Milanezi CM, Silva JS (2003). Patterns of chemokines and chemokine receptors expression in different forms of human periodontal disease. J Periodontal Res 38: 210-217.
15. Garlet GP, Martins W Jr, Fonseca BA, Ferreira BR, Silva JS (2004). Matrix metalloproteinases, their physiological inhibitors and osteoclast factors are differentially regulated by the cytokine profile in human periodontal disease. J Clin Periodontol 31: 671-679.
16. Gately MK, Renzetti LM, Magram J et al (1998). The interleukin-12/interleukin-12-receptor system: role in normal and pathologic immune responses. Annu Rev Immunol 16: 495-521.
17. Gorska R, Gregorek H, Kowalski J, Laskus-Perendyk A, Syczewska M, Madalinski K (2003). Relationship between clinical parameters and cytokine profiles in inflamed gingival tissue and serum samples from patients with chronic periodontitis. J Clin Periodontol 30: 1046-1052.
18. Graves D (2008). Cytokines that promote periodontal tissue destruction. J Periodontol 79: 1585-1591.
19. Graves DT, Cochran D (2003). The contribution of interleukin-1 and tumor necrosis factor to periodontal tissue destruction. J Periodontol 74: 391-401.
20. Honda T, Domon H, Okui T, Kajita K, Amanuma R, Yamazaki K (2006). Balance of inflammatory response in stable gingivitis and progressive periodontitis lesions. Clin Exp Immunol 144: 35-40.
21. Honda T, Aoki Y, Takahashi N et al (2008). Elevated expression of IL-17 and IL-12 genes in chronic inflammatory periodontal disease. Clin Chim Acta 395: 137-141.
22. Johnson RB, Serio FG (2005). Interleukin-18 concentrations and the pathogenesis of periodontal disease. J Periodontol 76: 785-790.
23. Johnson RB, Wood N, Serio FG (2005). Interleukin-11 and IL-17 and the pathogenesis of periodontal disease. J Periodontol 75: 37-43.
24. Lang N, Bartold P, Cullinan M et al (1999). Consensus report: aggressive periodontitis. Ann Periodontol 4: 53-53.
25. Lindhe J, Ranney R, Lamster I et al (1999). Consensus report: chronic periodontitis. Ann Periodontol 4: 38-38.
26. Loe H (1967). The gingival index, the plaque index and the retention index systems. J Periodontol 38(Suppl): 610-616.
27. Loos BG, Craandijk J, Hoek FJ, Wertheim-van Dillen PM, van der Velden U (2000). Elevation of systemic markers related to cardiovascular diseases in the peripheral blood of periodontitis patients. J Periodontol 71: 1528-1534.
28. Lopez Roa RI, Guerrero Velasquez C, Alvarado Navarro A, Montoya Buelna M, Garcia Niebla C, Fafutis Morris M (2008). Recovery of IFN-gamma levels in PBMCs from lepromatous leprosy patients through the synergistic actions of the cytokines IL-12 and IL-18. Int Immunopharmacol 8: 1715-1720.
29. Miranda LA, Fischer RG, Sztajnbok FR, Johansson A, Figueredo CM, Gustafsson A (2005). Increased interleukin-18 in patients with juvenile idiopathic arthritis and early attachment loss. J Periodontol 76: 75-82.
30. Murphy KM, Ouyang W, Farrar JD et al (2000). Signaling and transcription in T helper development. Annu Rev Immunol 18: 451-494.
31. Nakahira M, Ahn HJ, Park WR et al (2002). Synergy of IL-12 and IL-18 for IFN-gamma gene expression: IL-12-induced STAT4 contributes to IFN-gamma promoter activation by up-regulating the binding activity of IL-18-induced activator protein 1. J Immunol 168: 1146-1153.
32. Nakanishi K, Yoshimoto T, Tsutsui H, Okamura H (2001). Interleukin-18 is a unique cytokine that stimulates both Th1 and Th2 responses depending on its cytokine milieu. Cytokine Growth Factor Rev 12: 53-72.
33. Nau GJ, Schlesinger A, Richmond JF, Young RA (2003). Cumulative Toll-like receptor activation in human macrophages treated with whole bacteria. J Immunol 170: 5203-5209.
34. O'Garra A (1998). Cytokines induce the development of functionally heterogeneous T helper cell subsets. Immunity 8: 275-283.
35. Ohyama H, Kato-Kogoe N, Kuhara A et al (2009). The involvement of IL-23 and the Th17 pathway in periodontitis. J Dent Res 88: 633-638.
36. Okada H, Murakami S (1998). Cytokine expression in periodontal health and disease. Crit Rev Oral Biol Med 9: 248-266.
37. Okamura H, Tsutsi H, Komatsu T et al (1995). Cloning of a new cytokine that induces IFN-gamma production by T cells. Nature 378: 88-91.
38. Opal SM, DePalo VA (2000). Anti-inflammatory cytokines. Chest 117: 1162-1172.
39. Orozco A, Gemmell E, Bickel M, Seymour GJ (2006). Interleukin-1beta, interleukin-12 and interleukin-18 levels in gingival fluid and serum of patients with gingivitis and periodontitis. Oral Microbiol Immunol 21: 256-260.
40. Page RC, Kornman KS (1997). The pathogenesis of human periodontitis: an introduction. Periodontol 2000 14: 9-11.
41. Papapanou PN (1999). Epidemiology of periodontal diseases: an update. J Int Acad Periodontol 1: 110-116.
42. Petersen PE, Ogawa H (2005). Strengthening the prevention of periodontal disease: the WHO approach. J Periodontol 76: 2187-2193.
43. Pihlstrom BL, Michalowicz BS, Johnson NW (2005). Periodontal diseases. Lancet 366: 1809-1820.
44. Pradeep AR, Hadge P, Chowdhry S, Patel S, Happy D (2009). Exploring the role of Th1 cytokines: interleukin-17 and interleukin-18 in periodontal health and disease. J Oral Sci 51: 261-266.
45. Rai B, Kharb S, Jain R, Anand SC (2008). Biomarkers of periodontitis in oral fluids. J Oral Sci 50: 53-56.
46. Sato K, Suematsu A, Okamoto K et al (2006). Th17 functions as an osteoclastogenic helper T cell subset that links T cell activation and bone destruction. J Exp Med 203: 2673-2682.
47. Schenkein HA, Koertge TE, Brooks CN, Sabatini R, Purkall DE, Tew JG (2010). IL-17 in Sera from patients with aggressive periodontitis. J Dent Res 89: 943-947.
48. Schroder K, Hertzog PJ, Ravasi T, Hume DA (2004). Interferon-gamma: an overview of signals, mechanisms and functions. J Leukoc Biol 75: 163-189.
49. Seymour GJ (1991). Importance of the host response in the periodontium. J Clin Periodontol 18: 421-426.
50. Shi D, Meng H, Xu L et al (2008). Systemic inflammation markers in patients with aggressive periodontitis: a pilot study. J Periodontol 79: 2340-2346.
51. Stashenko P, Goncalves RB, Lipkin B, Ficarelli A, Sasaki H, Campos-Neto A (2007). Th1 immune response promotes severe bone resorption caused by Porphyromonas gingivalis. Am J Pathol 170: 203-213.
52. Suarez LJ, Ocampo AM, Duenas RE, Rodriguez A (2004). Relative proportions of T-cell subpopulations and cytokines that mediate and regulate the adaptive immune response in patients with aggressive periodontitis. J Periodontol 75: 1209-1215.
53. Sugano N, Ikeda K, Oshikawa M, Sawamoto Y, Tanaka H, Ito K (2004). Differential cytokine induction by two types of Porphyromonas gingivalis. Oral Microbiol Immunol 19: 121-123.
54. Takahashi K, Azuma T, Motohira H, Kinane DF, Kitetsu S (2005). The potential role of interleukin-17 in the immunopathology of periodontal disease. J Clin Periodontol 32: 369-374.
55. Taubman MA, Kawai T (2001). Involvement of T-lymphocytes in periodontal disease and in direct and indirect induction of bone resorption. Crit Rev Oral Biol Med 12: 125-135.
56. Teng YT (2003). The role of acquired immunity and periodontal disease progression. Crit Rev Oral Biol Med 14: 237-252.
57. Trinchieri G (2003). Interleukin-12 and the regulation of innate resistance and adaptive immunity. Nat Rev Immunol 3: 133-146.
58. Tsai IS, Tsai CC, Ho YP, Ho KY, Wu YM, Hung CC (2005). Interleukin-12 and interleukin-16 in periodontal disease. Cytokine 31: 34-40.
59. Van Dyke TE, Sheilesh D (2005). Risk factors for periodontitis. J Int Acad Periodontol 7: 3-7.
60. Vernal R, Leon R, Herrera D, Garcia-Sanz JA, Silva A, Sanz M (2008). Variability in the response of human dendritic cells stimulated with Porphyromonas gingivalis or Aggregatibacter actinomycetemcomitans. J Periodontal Res 43: 689-697.
61. Vernal R, Leon R, Silva A, van Winkelhoff AJ, Garcia-Sanz JA, Sanz M (2009). Differential cytokine expression by human dendritic cells in response to different Porphyromonas gingivalis capsular serotypes. J Clin Periodontol 36: 823-829.
62. Wang XY, Wang JL, Ding A, Sun Y, Wang QT (2008). Effects of Porphyromonas gingivalis on inflammatory factor secreted by human umbilical vein endothelial cells. Shanghai Kou Qiang Yi Xue 17: 395-399.
63. Watford WT, Moriguchi M, Morinobu A, O'Shea JJ (2003). The biology of IL-12: coordinating innate and adaptive immune responses. Cytokine Growth Factor Rev 14: 361-368.
64. Wright HJ, Matthews JB, Chapple IL, Ling-Mountford N, Cooper PR (2008). Periodontitis associates with a type 1 IFN signature in peripheral blood neutrophils. J Immunol 181: 5775-5784.
65. Yucel OO, Berker E, Gariboglu S, Otlu H (2008). Interleukin-11, interleukin-1beta, interleukin-12 and the pathogenesis of inflammatory periodontal diseases. J Clin Periodontol 35: 365-370.